TY - JOUR
T1 - Differential myotoxic and cytotoxic activities of pre-synaptic neurotoxins from papuan taipan (oxyuranus scutellatus) and irian jayan death adder (acanthophis rugosus) venoms
AU - Chaisakul, Janeyuth
AU - Parkington, Helena Cecilia
AU - Isbister, Geoffrey K
AU - Konstantakopoulos, Nicki
AU - Hodgson, Wayne Clarence
PY - 2013
Y1 - 2013
N2 - Pre-synaptic PLA2 neurotoxins are important components of many Australasian elapid snake venoms. These toxins disrupt neurotransmitter release. Taipoxin, a pre-synaptic neurotoxin isolated from the venom of the coastal taipan (Oxyuranus scutellatus), causes necrosis and muscle degeneration. The present study examined the myotoxic and cytotoxic activities of venoms from the Papuan taipan (O. scutellatus) and Irian Jayan death adder (Acanthophis rugosus), and also tested their pre-synaptic neurotoxins: cannitoxin and P-EPTX-Ar1a. Based on size-exclusion chromatography analysis, cannitoxin represents 16 of O. scutellatus venom, while P-EPTX-Ar1a represents 6 of A. rugosus venom. In the chick biventer cervicis nerve-muscle preparation, A. rugosus venom displayed significantly higher myotoxic activity than O. scutellatus venom as indicated by inhibition of direct twitches, and an increase in baseline tension. Both cannitoxin and P-EPTX-Ar1a displayed marked myotoxic activity. A. rugosus venom (50-300 mug/ml) produced concentration-dependent inhibition of cell proliferation in a rat skeletal muscle cell line (L6), while 300 mug/ml of O. scutellatus venom was required to inhibit cell proliferation, following 24-hr incubation. P-EPTX-Ar1a had greater cytotoxicity than cannitoxin, inhibiting cell proliferation after 24-hr incubation in L6 cells. Lactate dehydrogenase levels were increased after 1-hr incubation with A. rugosus venom (100-250 mug/ml), O. scutellatus venom (200-250 mug/ml) and P-EPTX-Ar1a (1-2 muM), but not cannitoxin (1-2 muM), suggesting venoms/toxin generated cell necrosis. Thus, A. rugosus and O. scutellatus venoms possess different myotoxic and cytotoxic activities. The proportion of pre-synaptic neurotoxin in the venoms and PLA2 activity of the whole venoms are unlikely to be responsible for these activities.
AB - Pre-synaptic PLA2 neurotoxins are important components of many Australasian elapid snake venoms. These toxins disrupt neurotransmitter release. Taipoxin, a pre-synaptic neurotoxin isolated from the venom of the coastal taipan (Oxyuranus scutellatus), causes necrosis and muscle degeneration. The present study examined the myotoxic and cytotoxic activities of venoms from the Papuan taipan (O. scutellatus) and Irian Jayan death adder (Acanthophis rugosus), and also tested their pre-synaptic neurotoxins: cannitoxin and P-EPTX-Ar1a. Based on size-exclusion chromatography analysis, cannitoxin represents 16 of O. scutellatus venom, while P-EPTX-Ar1a represents 6 of A. rugosus venom. In the chick biventer cervicis nerve-muscle preparation, A. rugosus venom displayed significantly higher myotoxic activity than O. scutellatus venom as indicated by inhibition of direct twitches, and an increase in baseline tension. Both cannitoxin and P-EPTX-Ar1a displayed marked myotoxic activity. A. rugosus venom (50-300 mug/ml) produced concentration-dependent inhibition of cell proliferation in a rat skeletal muscle cell line (L6), while 300 mug/ml of O. scutellatus venom was required to inhibit cell proliferation, following 24-hr incubation. P-EPTX-Ar1a had greater cytotoxicity than cannitoxin, inhibiting cell proliferation after 24-hr incubation in L6 cells. Lactate dehydrogenase levels were increased after 1-hr incubation with A. rugosus venom (100-250 mug/ml), O. scutellatus venom (200-250 mug/ml) and P-EPTX-Ar1a (1-2 muM), but not cannitoxin (1-2 muM), suggesting venoms/toxin generated cell necrosis. Thus, A. rugosus and O. scutellatus venoms possess different myotoxic and cytotoxic activities. The proportion of pre-synaptic neurotoxin in the venoms and PLA2 activity of the whole venoms are unlikely to be responsible for these activities.
UR - http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12048/pdf
U2 - 10.1111/bcpt.12048
DO - 10.1111/bcpt.12048
M3 - Article
SN - 1742-7835
VL - 112
SP - 325
EP - 334
JO - Basic & Clinical Pharmacology & Toxicology
JF - Basic & Clinical Pharmacology & Toxicology
IS - 5
ER -